Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00708006 · ClinicalTrials.gov registry record · Phase 1

A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumors, sponsored by Human Genome Sciences.

Completed
Registry status
Phase 1
Development phase
66
Enrollment target
3
Study locations

NCT00708006 is a Phase 1 study of Advanced Solid Tumors that has completed, run by Human Genome Sciences. The registered enrollment target is 66 participants, below the 198-participant average among 144 other Advanced Solid Tumors trials with a reported enrollment target (67% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00708006, a Phase 1 study of Advanced Solid Tumors, has completed, sponsored by Human Genome Sciences.

COMPLETED
Registry status
Phase 1
Development phase
66 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to evaluate the safety and tolerability of HGS1029 in subjects with advanced solid tumors and to determine a phase 2 dose.

Conditions Studied

Advanced Solid Tumors

Interventions

  • DRUG HGS1029

Study Locations (3)

California

  • Stanford University Dept. of Medicine-Oncology - Stanford

Colorado

  • University of Colorado Health Sciences Center - Aurora

Tennessee

  • The Sarah Cannon Research Institute - Nashville

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2008-05
Est. Completion 2012-01
Phase Phase 1

Sponsor

Human Genome Sciences

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00708006

The ClinicalTrials.gov registry entry for NCT00708006 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 198-participant average among 144 other Advanced Solid Tumors trials with a reported enrollment target (67% lower). The listed sponsor is Human Genome Sciences, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which HGS1029 is the first listed.

NCT00708006 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Colorado, Tennessee.

Frequently Asked Questions

What is clinical trial NCT00708006 about?

NCT00708006 is a clinical study titled "A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors". The purpose of this study is to evaluate the safety and tolerability of HGS1029 in subjects with advanced solid tumors and to determine a phase 2 dose.

What is the current status of trial NCT00708006?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2008-05. Estimated completion is 2012-01.

What conditions does trial NCT00708006 study?

This clinical trial studies the following conditions: Advanced Solid Tumors.

What interventions are being tested in trial NCT00708006?

The interventions under investigation include: HGS1029 (DRUG).

Who is sponsoring clinical trial NCT00708006?

This trial is sponsored by Human Genome Sciences, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00708006 being conducted?

This trial has 3 study locations across California, Colorado, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumors

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.